Nivolumab vs Paroxetine
Nivolumab vs Paroxetine: Overview
This comparison examines the pharmacological differences between Nivolumab and Paroxetine.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Paroxetine: Potent selective serotonin reuptake inhibitor with additional muscarinic and NE reuptake inhibition.
Pharmacokinetics
Half-life: Nivolumab — 27 days; Paroxetine — 21 hours.
Chemical Properties
Molecular Formula: Paroxetine — C19H20FNO3.
Molecular Weight: Paroxetine — 329.3730 g/mol.
Type: Nivolumab — Antibody; Paroxetine — Small molecule.